RACHAEL DALEY: Open Payments
NPI 1558577320 · AVONDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,044 in 126 payments from 18 companies in 2025. Trend: 2023 $1,761 · 2024 $2,047 · 2025 $2,044
Food & beverage: $2,044
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 53 | $675 |
| UCB, Inc. | 13 | $188 |
| Lundbeck LLC | 10 | $182 |
| PFIZER INC. | 12 | $180 |
| Alexion Pharmaceuticals, Inc. | 5 | $144 |
| EMD Serono, Inc. | 4 | $84 |
| Neurelis, Inc. | 2 | $79 |
| Lilly USA, LLC | 4 | $72 |
| SK Life Science, Inc. | 3 | $72 |
| Teva Pharmaceuticals USA, Inc. | 4 | $69 |
Products named: QULIPTA, UBRELVY, ULTOMIRIS, NURTEC ODT, REXULTI, Briviact, Rystiggo, VYEPTI.
Industry payments across AZ — which companies pay providers there.
